CMS Agrees to Cover ‘Breakthrough’ Medical Devices

CMS Agrees to Cover ‘Breakthrough’ Medical Devices

Medicare patients will have coverage for medical devices the FDA designates as breakthrough technology under a proposed rule released this morning. Once the Medicare Coverage of Innovative Technology (MCIT) final rule goes into effect, national Medicare coverage will begin on the date of a breakthrough device’s FDA market authorization would begin and continue for four years.

The MCIT pathway would be voluntary, and device manufacturers would notify the Centers for Medicare and Medicaid Services if they want to use this coverage option.“This coverage pathway delivers on the Administration’s commitment to give Medicare beneficiaries access to the newest innovations on the market, consistent with the statutory definitions of Medicare benefits.


Next Article

  • CMS Agrees to Cover ‘Breakthrough’ Medical Devices

    Optimize Reimbursement of Medical Charges - HealthStream

    According to a poll administered by Cardinal Health, healthcare decision makers reported reimbursement as the biggest problem facing health systems today. The failure to effectively capture charges, …

    Posted Sep 8, 2020

Did you find this useful?

Medigy Innovation Network

Connecting innovation decision makers to authoritative information, institutions, people and insights.

Medigy Logo

The latest News, Insights & Events

Medigy accurately delivers healthcare and technology information, news and insight from around the world.

The best products, services & solutions

Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.


© 2024 Netspective Media LLC. All Rights Reserved.

Built on Mar 28, 2024 at 3:00am